智通财经APP获悉，科济药业-B(02171)现跌近7%，截至发稿，跌5.95%，报6.95港元，成交额5429.62万港元。
消息面上，据财联社报道，记者根据今日发布的2024年国家医保目录发现，包括科济药业的泽沃基奥仑赛注射液在内的四款百万元CAR-T细胞疗法并未出现在目录名单之列。
值得注意的是，科济药业11月6日在公司官微上公布了其产品赛恺泽（泽沃基奥仑赛注射液）、CT071和CT0590的数据，并宣布这三项数据将在第66届美国血液学会（ASH）年会上以壁报形式展示，该会议将于12月7日至10日举行。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.